Skip to content

Public FDA record

Z-0950-03: Bindazyme, Human AntiCardiolipin IgM Enzyme Immunoassay Kits, MK029

Recall record Z-0950-03 for Binding Site Inc The. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0950-03
Company in FDA record
Binding Site Inc The
FDA classification date
Jun 21, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Risk of false positives.

Source facts

Action
Recall notice was sent by fax March 27, 2003. The recall is complete.
Initiated
2003-03-27
Root cause
Other
Terminated
2004-12-01
Distribution
Nationwide.
Recall number
Z-0950-03
Recall status
Terminated
CDRH record ID
27673
FDA classified
2003-06-21
Recall event number
26433

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗